Affinity of Nintedanib Towards New Candidate Target for Idiopathic Pulmonary Fibrosis

Affinity of Nintedanib Towards New Candidate Target for Idiopathic Pulmonary Fibrosis

Idiopathic pulmonary fibrosis (IPF) is a progressive disease due to aggregation of fibroblasts on lung parenchyma. Nintedanib, an indolinone-derived tyrosine kinase inhibitor (TKi) has been approved for the treatment of IPF and it is a well-known inhibitor of platelet-derived growth factor (PDGF) re...

Full description

Bibliographic Details
Main Authors: Hari Baskar Balasubramanian, Sima Biswas, Maria Talmon, Filippo Patrucco, Piero Emilio Balbo, Luigia Grazia Fresu, Angshuman Bagchi
Format: Article
Language:English
Published: Institute for Researches and Community Services Universitas Muhammadiyah Palangkaraya 2024-08-01
Series:Borneo Journal of Pharmacy
Subjects:
Nintedanib
Idiopathic Pulmonary Fibrosis
COACH server-Binding site predictor
ADMET-SAR properties
Online Access:https://journal.umpr.ac.id/index.php/bjop/article/view/7218

Internet

https://journal.umpr.ac.id/index.php/bjop/article/view/7218

Similar Items